NutriCare Plus a Medically Tailored Meal Intervention Among Patients With Lung Cancer
NCT04986670 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 299
Last updated 2025-09-30
Summary
The NutriCare study aims to develop, implement, and evaluate the efficacy of an innovative intervention strategy (medically tailored meals plus nutrition counseling) to integrate nutrition into the standard of care for oncology to improve outcomes of vulnerable patients with lung cancer. The NutriCare study evaluates the efficacy of the intervention on optimizing nutritional status, reducing treatment-related toxicities, and improving the quality of life of patients with lung cancer who are economically disadvantaged, uninsured, racial and ethnic minorities, elderly, and/or rural residents from four major medical centers in diverse regions of the United States (U.S.). There will be two cohorts for NutriCare with cohort 1 recruiting 150 patients completing an 8-month intervention and cohort 2 recruiting 120 patients completing a 6-month intervention.
Conditions
- Lung Cancer, Small Cell
- Lung Cancer Metastatic
- Lung Cancer Recurrent
- Treatment Side Effects
- Lung Cancer, Non-small Cell
- Nutritional Imbalance
Interventions
- BEHAVIORAL
-
Nutritional Counseling
Medical oncology providers will refer participants to oncology RDs for remotely delivered medical nutrition therapy counseling. For cohort 1, participants will receive nutrition counseling for 8 months. The counseling will be provided on a weekly basis during the first 6 months and every other week during the last 2 months (for cohort 1 only). For cohort 2, participants will receive nutrition counseling for 6 months. The ultimate frequency of nutrition counseling being provided to each participant will also be adjusted according to the participant's preference and needs.
- OTHER
-
Medically Tailored Meals (MTMs)
Medically tailored meals will be provided to participants in the intervention group for a total of 24 weeks for both cohorts. During the first 8 weeks of the intervention, 3 meals/day will be provided each week for a total of 168 meals per participant. It will be followed by less frequent meal provision during the subsequent 16 weeks following this schedule: 3 meals/day will be provided every other week for the next 8 weeks (a total of 84 meals per participant); and 3 meals/day will be provided every four weeks during the last 8 weeks (a total of 42 meals per participant). The number of meals provided to each participant may be adjusted according to participant's preference and needs.
- BEHAVIORAL
-
Nutrition Prescription
Oncology providers will advise participants with lung cancer to follow evidence-based nutrition recommendations using a Nutrition Prescription. The Nutrition Prescription aims to enhance providers' role in communicating basic nutrition advice to participants with lung cancer. It contains seven recommendations, adapted from the newly released Cancer Prevention Recommendations by WCRF/AICR with strong evidence-base.
- OTHER
-
Nutrition Assessment
Oncology care providers will assess the nutritional status of patients with lung cancer using PG-SGA Short Form (the Scored Patient-Generated Subjective Global Assessment). PG-SGA is an interdisciplinary patient assessment in oncology and other chronic catabolic conditions. The short form contains four patient generated historical components (weight history, food intake symptoms, and activities and function).
- BEHAVIORAL
-
Nutrition Toolkit
Patients will receive a printed copy of a Nutrition Toolkit from providers. Evidence-based nutrition recommendations have been compiled for cancer survivors from 4 sources into a Nutrition Toolkit. The sources include: (1) AmericanCancer Society (ACS) Nutrition and Physical Activity Guidelines for Cancer Survivors; (2)World Cancer Research Fund / American Institute for Cancer Research (WFRF/AICR) Cancer Nutrition Guide; (3) National Cancer Institute (NCI) Eating Hints; and (4) National Comprehensive Cancer Network (NCCN) Guidelines for Cancer Survivors. The Nutrition Toolkit outlines topics about the impact of cancer treatment on dietary intake patterns and quality, strategies to manage treatment-related eating issues, maintaining a healthy weight post treatment, and evidence-based recommendations and practical. Nutrition Toolkit strategies for improving diet quality and maintaining an optimal weight for cancer survivors.
- BEHAVIORAL
-
Monthly Emails
Monthly emails will be sent to participants to encourage the use of the toolkit with healthy recipes and general nutrition information.
Sponsors & Collaborators
-
Fox Chase Cancer Center
collaborator OTHER -
M.D. Anderson Cancer Center
collaborator OTHER -
Ohio State University
collaborator OTHER -
Tufts Medical Center
collaborator OTHER -
Tufts University
lead OTHER
Principal Investigators
-
FangFang Zhang, MD, PhD · Tufts University
-
Colleen Spees, PhD, MEd, RD, LD, FAND · Ohio State University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-24
- Primary Completion
- 2024-12-31
- Completion
- 2026-12-31
Countries
- United States
Study Locations
More Related Trials
-
Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors
NCT06654245 ·Status: TERMINATED ·Phase: NA
-
Nutritional Status in Locally Advanced or Metastatic Solid Cancer Patients in Spain: the NutriOncoSearch (NOS) Study
NCT04168814 ·Status: COMPLETED
-
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years
NCT05404022 ·Status: COMPLETED ·Phase: NA
-
The Study of High-protein Nutritional Support Impact on Postoperative Outcomes in Patients With Primary Lung Cancer
NCT05710354 ·Status: COMPLETED
-
Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction
NCT03326570 ·Status: COMPLETED
-
Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
NCT06684418 ·Status: RECRUITING
-
Feasibility of an Activity Regimen in Patients With Advanced Stage Lung Cancer
NCT03352245 ·Status: COMPLETED ·Phase: NA
-
Metformin in Non Small Cell Lung Cancer (NSCLC)
NCT02285855 ·Status: TERMINATED ·Phase: PHASE2
-
Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
NCT00450567 ·Status: COMPLETED
-
Effect of Compound Amino Acid Tablets on Nutritional Status of Patients With Lung Cancer
NCT05770063 ·Status: UNKNOWN ·Phase: NA
-
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
NCT00003006 ·Status: COMPLETED
-
Patient-Defined Treatment Success and Preferences in Stage IV Lung Cancer Patients
NCT02190864 ·Status: UNKNOWN
-
A Prospective Study of Electronic Symptom Reporting Via Mobile Phone Among Patients With Advanced Non-Small Cell Lung Cancer
NCT03616522 ·Status: COMPLETED
-
Lung Cancer Screening: A Multilevel Intervention
NCT03862001 ·Status: COMPLETED ·Phase: NA
-
Understanding Evidence-Based Practice Patterns in Advanced NSCLC
NCT03107156 ·Status: COMPLETED ·Phase: NA
-
Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer
NCT01012401 ·Status: COMPLETED ·Phase: NA
-
Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC
NCT00483015 ·Status: COMPLETED
-
Evaluation of Stents to Open Restricted Airways in Patients With Centrally Placed Non-small Cell Lung Cancer
NCT01003522 ·Status: UNKNOWN ·Phase: PHASE3
-
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery
NCT00732563 ·Status: COMPLETED ·Phase: NA
-
The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC
NCT05902260 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis
NCT04516070 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Longitudinal Study of Multiple Symptoms in Advanced Lung Cancer
NCT00422500 ·Status: COMPLETED
-
Adjuvant Chemotherapy for High-Risk Pathologic Stage I Non-Squamous NSCLC
NCT07250360 ·Status: COMPLETED
-
Reducing Insulin, Growth Hormones, and Tumors
NCT03785808 ·Status: TERMINATED ·Phase: NA
-
Multimodal Intervention for Patients With Non-small Cell Lung Cancer
NCT04161794 ·Status: COMPLETED ·Phase: NA